29th Napa Pain Conference (2022) - 2022 NPC Poster Hall - Neurovations

Real-World Pain Relief Outcomes Using an Interspinous Spacer for Treatment of Lumbar Spinal Stenosis



Synopsis

Effective leg pain responder rate and pain severity have been previously demonstrated In patients implanted with an Interspinous Spacer out to 12-months post-operation. This is a consecutive, multi-center, case-series based on retrospective chart review as part of an on-going, real­-world evaluation of Indirect Decompression Systems (IDS) outcomes for lumbar spinal stenosis. Patients reported a mean NRS pain score 9.4 ± 0.5 prior to IDS implant, and a 5.4-point improvement (p<0.0001, n = 41) was reported at last follow-up (mean = 115 days). The preliminary evidence derived from this on-going, real-world observational case-series aligns so far with other published reports.


Disclosures

  • Study Sponsored by Boston Scientific. 
  • Consulting Agreement with Boston Scientific: Drs. Esposito, Ferro, Wilson, Hatheway, Moore, and Jameson. 
  • Employees of Boston Scientific: Holly Kaufman, Lilly Chen and Roshini Jain

Author(s):
Track: Poster


Display Label Action
Esposito IDS Outcomes Napa 2022_e-poster Download Poster
08_Esposito - Real-World Pain Relief Outcomes Using an Interspinous Spacer Download Abstract